Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ryan, E. A.
Right arrow Articles by Shapiro, A.M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ryan, E. A.
Right arrow Articles by Shapiro, A.M. J.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes 51:2148-2157, 2002
© 2002 by the American Diabetes Association, Inc.

Successful Islet Transplantation

Continued Insulin Reserve Provides Long-Term Glycemic Control

Edmond A. Ryan1, Jonathan R.T. Lakey2,3, Breay W. Paty1, Sharleen Imes4, Gregory S. Korbutt3, Norman M. Kneteman2, David Bigam2, Ray V. Rajotte3, and A.M. James Shapiro2

1 Department of Medicine, Clinical Islet Transplant Program, University of Alberta and Capital Health Authority, Edmonton, Alberta, Canada
2 Department of Surgery, Clinical Islet Transplant Program, University of Alberta and Capital Health Authority, Edmonton, Alberta, Canada
3 Surgical Medical Research Institute, Clinical Islet Transplant Program, University of Alberta and Capital Health Authority, Edmonton, Alberta, Canada
4 Capital Health Authority, Edmonton, Alberta, Canada

Clinical islet transplantation is gaining acceptance as a potential therapy, particularly for subjects who have labile diabetes or problems with hypoglycemic awareness. The risks of the procedure and long-term outcomes are still not fully known. We have performed 54 islet transplantation procedures on 30 subjects and have detailed follow-up in 17 consecutive Edmonton protocol-treated subjects who attained insulin independence after transplantation of adequate numbers of islets. Subjects were assessed pretransplant and followed prospectively posttransplant for immediate and long-term complications related to the procedure or immunosuppressive therapy. The 17 patients all became insulin independent after a minimum of 9,000 islets/kg were transplanted. Of 15 consecutive patients with at least 1 year of follow-up after the initial transplant, 12 (80%) were insulin independent at 1 year. In 14 subjects who have maintained demonstrable C-peptide secretion, glucose control has been stable and glycemic lability and problems with hypoglycemic reactions have been corrected. After 2 of the 54 procedures, some thrombosis was detected in the portal vein circulation. Five subjects had bleeding related to the percutaneous portal vein access procedures: three required transfusion alone, and in one subject, who had a partial thrombosis of the portal vein, an expanding intrahepatic and subscapular hemorrhage occurred while on anticoagulation, requiring transfusion and surgery. Elevated liver function test results were found in 46% of subjects but resolved in all. Complications related to the therapy have been hypercholesterolemia requiring statin therapy in 65%; a rise in creatinine in two patients, both of whom had preexisting renal disease; a rise in protein in four, all of whom had preexisting proteinuria; and antihypertensive therapy increased or started in 53%. Three of the 17 patients have required retinal laser photocoagulation. There have been no cases of posttransplant lymphoproliferative disorder or cytomegalovirus infection, and no deaths. The acute insulin response to arginine correlated better with transplanted islet mass than acute insulin response to glucose (AIRg) and area under the curve for insulin (AUCi), but the AIRg and AUCi were more closely related to glycemic control. The AUCi directly posttransplant was lower in those who eventually became C-peptide deficient. Our results, with a maximum follow-up of 34 months, indicate that prolonged insulin independence can be achieved after islet transplantation. There are some risks associated acutely with the procedure, and hypercholesterolemia and hypertension are treatable concerns on longer-term follow-up. All patients with persisting C-peptide secretion have had a resolution of both glycemic lability and problems with hypoglycemic reactions. Apart from the rise in serum creatinine in two subjects, no serious consequences of immunosuppressive therapy have been encountered. Islet transplantation is a reasonable option in those with severe problems with glycemic lability or hypoglycemia.


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 DiabetesHome page
R. P. Robertson
Estimation of {beta}-Cell Mass by Metabolic Tests: Necessary, but How Sufficient?
Diabetes, October 1, 2007; 56(10): 2420 - 2424.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Su, N. Zhang, J. He, S. Qu, S. Slusher, R. Bottino, S. Bertera, J. Bromberg, and H. H. Dong
Angiopoietin-1 Production in Islets Improves Islet Engraftment and Protects Islets From Cytokine-Induced Apoptosis
Diabetes, September 1, 2007; 56(9): 2274 - 2283.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. Maffi, F. Bertuzzi, F. De Taddeo, P. Magistretti, R. Nano, P. Fiorina, A. Caumo, P. Pozzi, C. Socci, M. Venturini, et al.
Kidney Function After Islet Transplant Alone in Type 1 Diabetes: Impact of immunosuppressive therapy on progression of diabetic nephropathy
Diabetes Care, May 1, 2007; 30(5): 1150 - 1155.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
P Srinivasan, G C Huang, S A Amiel, and N D Heaton
Islet cell transplantation
Postgrad. Med. J., April 1, 2007; 83(978): 224 - 229.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Lehmann, R. A. Zuellig, P. Kugelmeier, P. B. Baenninger, W. Moritz, A. Perren, P.-A. Clavien, M. Weber, and G. A. Spinas
Superiority of Small Islets in Human Islet Transplantation
Diabetes, March 1, 2007; 56(3): 594 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
F. Bertuzzi and C. Ricordi
Prediction of Clinical Outcome in Islet Allotransplantation
Diabetes Care, February 1, 2007; 30(2): 410 - 417.
[Full Text] [PDF]

Home page
 Proc. Natl. Acad. Sci. USAHome page
B. Keymeulen, P. Gillard, C. Mathieu, B. Movahedi, G. Maleux, G. Delvaux, D. Ysebaert, B. Roep, E. Vandemeulebroucke, M. Marichal, et al.
Correlation between beta cell mass and glycemic control in type 1 diabetic recipients of islet cell graft
PNAS, November 14, 2006; 103(46): 17444 - 17449.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. H. Tai, P. Foster, A. Rosales, B. Feng, C. Hasilo, V. Martinez, S. Ramadan, J. Snir, C.W. J. Melling, S. Dhanvantari, et al.
Imaging Islets Labeled With Magnetic Nanoparticles at 1.5 Tesla
Diabetes, November 1, 2006; 55(11): 2931 - 2938.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
A.M. J. Shapiro, C. Ricordi, B. J. Hering, H. Auchincloss, R. Lindblad, R. P. Robertson, A. Secchi, M. D. Brendel, T. Berney, D. C. Brennan, et al.
International Trial of the Edmonton Protocol for Islet Transplantation.
N. Engl. J. Med., September 28, 2006; 355(13): 1318 - 1330.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. V. Evgenov, Z. Medarova, J. Pratt, P. Pantazopoulos, S. Leyting, S. Bonner-Weir, and A. Moore
In Vivo Imaging of Immune Rejection in Transplanted Pancreatic Islets
Diabetes, September 1, 2006; 55(9): 2419 - 2428.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Zhang, D. Su, S. Qu, T. Tse, R. Bottino, A.N. Balamurugan, J. Xu, J. S. Bromberg, and H. H. Dong
Sirolimus Is Associated With Reduced Islet Engraftment and Impaired {beta}-Cell Function
Diabetes, September 1, 2006; 55(9): 2429 - 2436.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
A. S. Narang and R. I. Mahato
Biological and biomaterial approaches for improved islet transplantation.
Pharmacol. Rev., June 1, 2006; 58(2): 194 - 243.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Rickels, A. Naji, and K. L. Teff
Insulin Sensitivity, Glucose Effectiveness, and Free Fatty Acid Dynamics after Human Islet Transplantation for Type 1 Diabetes
J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2138 - 2144.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S.-H. Ihm, I. Matsumoto, T. Sawada, M. Nakano, H. J. Zhang, J. D. Ansite, D. E.R. Sutherland, and B. J. Hering
Effect of donor age on function of isolated human islets.
Diabetes, May 1, 2006; 55(5): 1361 - 1368.
[Abstract] [Full Text] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
Y. Lu, Z. Wang, and M. Zhu
Human bone marrow mesenchymal stem cells transfected with human insulin genes can secrete insulin stably.
Ann. Clin. Lab. Sci., March 1, 2006; 36(2): 127 - 136.
[Abstract] [Full Text] [PDF]

Home page
 J EndocrinolHome page
D. A Taylor-Fishwick, W. Shi, G. L Pittenger, and A. I Vinik
PDX-1 can repress stimulus-induced activation of the INGAP promoter.
J. Endocrinol., March 1, 2006; 188(3): 611 - 621.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
F. Dombrowski, C. Mathieu, and M. Evert
Hepatocellular Neoplasms Induced by Low-Number Pancreatic Islet Transplants in Autoimmune Diabetic BB/Pfd Rats
Cancer Res., February 1, 2006; 66(3): 1833 - 1843.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
T. B. Thornley, M. A. Brehm, T. G. Markees, L. D. Shultz, J. P. Mordes, R. M. Welsh, A. A. Rossini, and D. L. Greiner
TLR Agonists Abrogate Costimulation Blockade-Induced Prolongation of Skin Allografts
J. Immunol., February 1, 2006; 176(3): 1561 - 1570.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
R. Calafiore, G. Basta, G. Luca, A. Lemmi, M. P. Montanucci, G. Calabrese, L. Racanicchi, F. Mancuso, and P. Brunetti
Microencapsulated Pancreatic Islet Allografts Into Nonimmunosuppressed Patients With Type 1 Diabetes: First two cases
Diabetes Care, January 1, 2006; 29(1): 137 - 138.
[Full Text] [PDF]

Home page
 J. Exp. Med.Home page
Y. Yasunami, S. Kojo, H. Kitamura, A. Toyofuku, M. Satoh, M. Nakano, K. Nabeyama, Y. Nakamura, N. Matsuoka, S. Ikeda, et al.
V{alpha}14 NK T cell-triggered IFN-{gamma} production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets
J. Exp. Med., October 3, 2005; 202(7): 913 - 918.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. A. Emamaullee, R. V. Rajotte, P. Liston, R. G. Korneluk, J. R.T. Lakey, A.M. J. Shapiro, and J. F. Elliott
XIAP Overexpression in Human Islets Prevents Early Posttransplant Apoptosis and Reduces the Islet Mass Needed to Treat Diabetes
Diabetes, September 1, 2005; 54(9): 2541 - 2548.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
W. L. Suarez-Pinzon, Y. Yan, R. Power, S. J. Brand, and A. Rabinovitch
Combination Therapy With Epidermal Growth Factor and Gastrin Increases {beta}-Cell Mass and Reverses Hyperglycemia in Diabetic NOD Mice
Diabetes, September 1, 2005; 54(9): 2596 - 2601.
[Abstract] [Full Text] [PDF]

Home page
 QJMHome page
P. Narendran, E. Estella, and S. Fourlanos
Immunology of type 1 diabetes
QJM, August 1, 2005; 98(8): 547 - 556.
[Full Text] [PDF]

Home page
 DiabetesHome page
E. A. Ryan, B. W. Paty, P. A. Senior, D. Bigam, E. Alfadhli, N. M. Kneteman, J. R.T. Lakey, and A.M. J. Shapiro
Five-Year Follow-Up After Clinical Islet Transplantation
Diabetes, July 1, 2005; 54(7): 2060 - 2069.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. L. Suarez-Pinzon, J. R. T. Lakey, S. J. Brand, and A. Rabinovitch
Combination Therapy with Epidermal Growth Factor and Gastrin Induces Neogenesis of Human Islet {beta}-Cells from Pancreatic Duct Cells and an Increase in Functional {beta}-Cell Mass
J. Clin. Endocrinol. Metab., June 1, 2005; 90(6): 3401 - 3409.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
P. Rao, J. Roccisana, K. K. Takane, R. Bottino, A. Zhao, M. Trucco, and A. Garcia-Ocana
Gene Transfer of Constitutively Active Akt Markedly Improves Human Islet Transplant Outcomes in Diabetic Severe Combined Immunodeficient Mice
Diabetes, June 1, 2005; 54(6): 1664 - 1675.
[Abstract] [Full Text] [PDF]

Home page
 J Mol EndocrinolHome page
M. O Wilson, K. T Scougall, J. Ratanamart, E. A McIntyre, and J. A M Shaw
Tetracycline-regulated secretion of human (pro)insulin following plasmid-mediated transfection of human muscle
J. Mol. Endocrinol., April 1, 2005; 34(2): 391 - 403.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
T. Kin, G. S. Korbutt, T. Kobayashi, J. M. Dufour, and R. V. Rajotte
Reversal of Diabetes in Pancreatectomized Pigs After Transplantation of Neonatal Porcine Islets
Diabetes, April 1, 2005; 54(4): 1032 - 1039.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
S. Schneider, P. J. Feilen, F. Brunnenmeier, T. Minnemann, H. Zimmermann, U. Zimmermann, and M. M. Weber
Long-Term Graft Function of Adult Rat and Human Islets Encapsulated in Novel Alginate-Based Microcapsules After Transplantation in Immunocompetent Diabetic Mice
Diabetes, March 1, 2005; 54(3): 687 - 693.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
E. A. Ryan, B. W. Paty, P. A. Senior, J. R.T. Lakey, D. Bigam, and A.M. J. Shapiro
{beta}-Score: An assessment of {beta}-cell function after islet transplantation
Diabetes Care, February 1, 2005; 28(2): 343 - 347.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
M. Venturini, E. Angeli, P. Maffi, P. Fiorina, F. Bertuzzi, M. Salvioni, F. De Cobelli, C. Socci, L. Aldrighetti, C. Losio, et al.
Technique, Complications, and Therapeutic Efficacy of Percutaneous Transplantation of Human Pancreatic Islet Cells in Type 1 Diabetes: The Role of US
Radiology, February 1, 2005; 234(2): 617 - 624.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
M. R. Rickels, M. H. Schutta, J. F. Markmann, C. F. Barker, A. Naji, and K. L. Teff
{beta}-Cell Function Following Human Islet Transplantation for Type 1 Diabetes
Diabetes, January 1, 2005; 54(1): 100 - 106.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
C. N. Street, J. R.T. Lakey, A.M. J. Shapiro, S. Imes, R. V. Rajotte, E. A. Ryan, J. G. Lyon, T. Kin, J. Avila, T. Tsujimura, et al.
Islet Graft Assessment in the Edmonton Protocol: Implications for Predicting Long-Term Clinical Outcome
Diabetes, December 1, 2004; 53(12): 3107 - 3114.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
G. C. Weir and S. Bonner-Weir
Five Stages of Evolving Beta-Cell Dysfunction During Progression to Diabetes
Diabetes, December 1, 2004; 53(suppl_3): S16 - S21.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Bottino, A.N. Balamurugan, H. Tse, C. Thirunavukkarasu, X. Ge, J. Profozich, M. Milton, A. Ziegenfuss, M. Trucco, and J. D. Piganelli
Response of Human Islets to Isolation Stress and the Effect of Antioxidant Treatment
Diabetes, October 1, 2004; 53(10): 2559 - 2568.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
S M Selkirk
Gene therapy in clinical medicine
Postgrad. Med. J., October 1, 2004; 80(948): 560 - 570.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Han, X. Xu, D. Baidal, J. Leith, C. Ricordi, R. Alejandro, and N. S. Kenyon
Assessment of Cytotoxic Lymphocyte Gene Expression in the Peripheral Blood of Human Islet Allograft Recipients: Elevation Precedes Clinical Evidence of Rejection
Diabetes, September 1, 2004; 53(9): 2281 - 2290.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
Q. Shi, D. Wang, G. A. Hadley, A. W. Bingaman, S. T. Bartlett, and D. L. Farber
Long-Term Islet Graft Survival in NOD Mice by Abrogation of Recurrent Autoimmunity
Diabetes, September 1, 2004; 53(9): 2338 - 2345.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
G. S. Eisenbarth and P. A. Gottlieb
Autoimmune Polyendocrine Syndromes
N. Engl. J. Med., May 13, 2004; 350(20): 2068 - 2079.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
C. Greenbaum, K. Seidel, and C. Pihoker
The Case for Intravenous Arginine Stimulation In Lieu of Mixed-Meal Tolerance Tests as Outcome Measure for Intervention Studies in Recent-Onset Type 1 Diabetes
Diabetes Care, May 1, 2004; 27(5): 1202 - 1204.
[Full Text] [PDF]

Home page
 DiabetesHome page
G. Mattsson, L. Jansson, A. Nordin, A. Andersson, and P.-O. Carlsson
Evidence of Functional Impairment of Syngeneically Transplanted Mouse Pancreatic Islets Retrieved from the Liver
Diabetes, April 1, 2004; 53(4): 948 - 954.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
E. A. Ryan, T. Shandro, K. Green, B. W. Paty, P. A. Senior, D. Bigam, A.M. J. Shapiro, and M.-C. Vantyghem
Assessment of the Severity of Hypoglycemia and Glycemic Lability in Type 1 Diabetic Subjects Undergoing Islet Transplantation
Diabetes, April 1, 2004; 53(4): 955 - 962.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
N. Zhang, A. Richter, J. Suriawinata, S. Harbaran, J. Altomonte, L. Cong, H. Zhang, K. Song, M. Meseck, J. Bromberg, et al.
Elevated Vascular Endothelial Growth Factor Production in Islets Improves Islet Graft Vascularization
Diabetes, April 1, 2004; 53(4): 963 - 970.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
A. Lechner, Y.-G. Yang, R. A. Blacken, L. Wang, A. L. Nolan, and J. F. Habener
No Evidence for Significant Transdifferentiation of Bone Marrow Into Pancreatic {beta}-Cells In Vivo
Diabetes, March 1, 2004; 53(3): 616 - 623.
[Abstract] [Full Text] [PDF]

Home page
 NEJMHome page
R. P. Robertson
Islet Transplantation as a Treatment for Diabetes -- A Work in Progress
N. Engl. J. Med., February 12, 2004; 350(7): 694 - 705.
[Full Text] [PDF]

Home page
 EndocrinologyHome page
D. M. Harlan
Gene-Altered Islets for Transplant: Giant Leap or Small Step?
Endocrinology, February 1, 2004; 145(2): 463 - 466.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
J. A. Johnson, M. Kotovych, E. A. Ryan, and A.M. J. Shapiro
Reduced Fear of Hypoglycemia in Successful Islet Transplantation
Diabetes Care, February 1, 2004; 27(2): 624 - 625.
[Full Text] [PDF]

Home page
 DiabetesHome page
A. Omer, V. F. Duvivier-Kali, W. Aschenbach, V. Tchipashvili, L. J. Goodyear, and G. C. Weir
Exercise Induces Hypoglycemia in Rats With Islet Transplantation
Diabetes, February 1, 2004; 53(2): 360 - 365.
[Abstract] [Full Text]

Home page
 J. Biol. Chem.Home page
X. Li, H. Chen, and P. N. Epstein
Metallothionein Protects Islets from Hypoxia and Extends Islet Graft Survival by Scavenging Most Kinds of Reactive Oxygen Species
J. Biol. Chem., January 2, 2004; 279(1): 765 - 771.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
B. Hirshberg, K. I. Rother, B. J. Digon III, J. Lee, J. L. Gaglia, K. Hines, E. J. Read, R. Chang, B. J. Wood, and D. M. Harlan
Benefits and Risks of Solitary Islet Transplantation for Type 1 Diabetes Using Steroid-Sparing Immunosuppression: The National Institutes of Health experience
Diabetes Care, December 1, 2003; 26(12): 3288 - 3295.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
J. L. Contreras, C. Eckstein, C. A. Smyth, M. T. Sellers, M. Vilatoba, G. Bilbao, F. G. Rahemtulla, C. J. Young, J. A. Thompson, I. H. Chaudry, et al.
Brain Death Significantly Reduces Isolated Pancreatic Islet Yields and Functionality In Vitro and In Vivo After Transplantation in Rats
Diabetes, December 1, 2003; 52(12): 2935 - 2942.
[Abstract] [Full Text] [PDF]

Home page
 RadiologyHome page
R. J. T. Owen, E. A. Ryan, K. O'Kelly, J. R. T. Lakey, M. C. McCarthy, B. W. Paty, D. L. Bigam, N. M. Kneteman, G. S. Korbutt, R. V. Rajotte, et al.
Percutaneous Transhepatic Pancreatic Islet Cell Transplantation in Type 1 Diabetes Mellitus: Radiologic Aspects
Radiology, October 1, 2003; 229(1): 165 - 170.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
R. Gao, J. Ustinov, M.-A. Pulkkinen, K. Lundin, O. Korsgren, and T. Otonkoski
Characterization of Endocrine Progenitor Cells and Critical Factors for Their Differentiation in Human Adult Pancreatic Cell Culture
Diabetes, August 1, 2003; 52(8): 2007 - 2015.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
A. M. J. Shapiro
Islet Transplants and Impact on Secondary Diabetic Complications: Does C-Peptide Protect the Kidney?
J. Am. Soc. Nephrol., August 1, 2003; 14(8): 2214 - 2216.
[Full Text] [PDF]

Home page